Eveline Xavier-Souza

Eveline Xavier-Souza

Auto-generated profile, based on publicly available information

Eveline Xavier-Souza

Universidade Federal da Bahia, Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2016 in The Brazilian Journal of Infectious Diseases
Verified
Journal Article
Open access
ATAna Gabriela Travassos
Ana Gabriela Travassos
EXEveline Xavier-Souza
Eveline Xavier-Souza
ENEduardo Martins Netto
Eduardo Martins Netto
EDEda Vinhaes Dantas
Eda Vinhaes Dantas
MTMaiara Timbó
Maiara Timbó
CBCarlos Brites
Carlos Brites
Infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae are the most common bacterial sexually transmitted infections throughout the world. These sexually transmitted infections are a growing problem in people living with HIV/AIDS. However, the presence of these agents in extra genital sites, remains poorly studied in our country. The objective of this study was to estimate the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae anal and genital infection in people living with HIV/AIDS followed in a reference center in Salvador, Brazil. Cross-sectional study, from June 2013 to June 2015. Proven HIV-infected people attending this reference center were invited. Clinical and epidemiological data were obtained through interview with standardized form. Chlamydia trachomatis and Neisseria gonorrhoeae screening was performed using qPCR (COBAS 4800® Roche). The frequency of positive cases of Chlamydia trachomatis and Neisseria gonorrhoeae was 12.3% in total, 9.2% cases amongst women and 17.1% amongst men. We found 14.0% of positive cases in anus and 3.1% in genital region in men, while 5.6% and 3.6%, in women, respectively. Among men, anal infection was associated with age <29 years (p=0.033), report of anal intercourse (p=0.029), pain during anal intercourse (p=0.028). On the other hand, no association between genital infection and other variables were detected in bivariate analysis. Among women, we detected an association between Chlamydia trachomatis genital infection and age <29 years (p<0.001), younger age at first sexual intercourse (p=0.048), pregnancy (p50copies/mL (p=0.020), and no antiretroviral use (p=0.008). Anal infection in women was associated with age <29 years old (p<0.001) and pregnancy (p=0.023), and was not associated with report of anal intercourse (p=0.485). Missed opportunities for diagnosis in extra genital sites could impact on HIV transmission. The extra genital sites need to be considered to break the HIV and bacterial sexually transmitted infections chain-of-transmission.

1 January 2023 in Jornal Brasileiro de Doenças Sexualmente Transmissíveis
Verified
Journal Article
Open access
PDF file
VSVinicius Nascimento dos Santos
Vinicius Nascimento dos Santos
ESEveline Xavier Pereira de Souza
Eveline Xavier Pereira de Souza
MTMaiara Santos Timbó
Maiara Santos Timbó
ATAna Gabriela Travassos
Ana Gabriela Travassos
Introduction: Post-exposure prophylaxis (PEP) is the use of antiretroviral drugs (ARVs) to reduce the risk of human immunodeficiency virus (HIV) infection after potential risk exposure. ARV-based interventions are recommended as part of combination HIV prevention, especially for key populations. Objective: The aim of this study was to measure knowledge about PEP among university students. Methods: A cross-sectional study was conducted on university students from the Health, Education, Exact, and Human Sciences Departments of the State University of Bahia, Brazil. Sociodemographic data, information on sexual behavior, and knowledge of PEP were collected through a standardized self-applied questionnaire. Results: We analyzed 1580 questionnaires, of which 66.7% (1024/1536) were from females, with a mean age of 23.9 (±6.5) years, and 35.4% (448/1264) reported irregular use of condoms and regular use was not associated with being students from the health area (p=0.44, OR 0.90, 95%CI 0.69–1.17). Regarding PEP, 28.5% (449/1578) had known about it and their knowledge was statistically associated with men who have sex with men (MSM) (p<0.01, OR 3.92, 95%CI 2.45–6.28). It was noted that 94.0% (1485/1579) did not know the time limit for starting PEP, 95.1% (1500/1578) did not know the duration of prophylaxis, and 91.1% (1437/1577) did not know where to get PEP. Finally, 0.4% (7/1578) referred to previous use and 96.6% (1488/1540) would not change their sexual behavior after knowing about PEP. Conclusion: PEP is a prevention strategy available for decades and is safe, effective, and cost-effective. However, it is underutilized and a lack of knowledge on PEP is one of the main obstacles to access. Among university students, there is a limited knowledge about PEP acting as a barrier in preventing new infections, which shows the need for interventions based on sexual-health education, stimulating the reduction of risk behaviors and disseminating information about combination prevention.

1 January 2019 in Jornal Brasileiro de Doenças Sexualmente Transmissíveis
Verified
Journal Article
Open access
AAAlyce Lima Amorim
Alyce Lima Amorim
ATAna Gabriela Travassos
Ana Gabriela Travassos
GSGeovane Cruz de Souza
Geovane Cruz de Souza
VFVitor Cunha Fontes
Vitor Cunha Fontes
MTMaiara Timbó
Maiara Timbó
ESEveline Xavier Souza
Eveline Xavier Souza
Introduction: Ureaplasma urealyticum and Mycoplasma hominis are frequently found at many women’s and men’s urogenital tract, and have been associated with non-gonococcal urethritis, cervicitis, infertility, chorioaminionitis and adverse pregnancy outcomes. Some studies show high prevalence of human papillomavirus (HPV) in patients with non-gonococcal urethritis, while also presenting high frequency of Ureaplasma urealyticum infection in women with cervicalcytology abnormalities and men with genital warts. Objectives: To evaluate the prevalence of Ureaplasma urealyticum, Mycoplasma hominis and HPV coinfection in people attending a sexually transmitted infections (STI)/HIV reference centre and to identify the risk factors associated. Methods: A cross-sectional study with patients aged >18 years, carried out for Ureaplasma urealyticum and Mycoplasma hominis from July 1st to December 31, 2015, in a STI/HIV reference centre from the State of Bahia, Brazil. Sociodemographic and clinical data were obtained from secondary data from patients’ charts and laboratory findings, and analyzed using SPSS 20.0. Pearson’s χ2 test or Fisher’s exact test was used to evaluate categorical variables. HPV clinical diagnosis was considered positive as the presence of genital warts. Results: In this study, 849 patients were included — 196 men and 653 women. Of the sample, 51.4% was diagnosed with at least one of the two bacteria. The prevalence of Mycoplasma hominis infection was higher in coinfection (16.7%) than in isolated infection (2.2%). The prevalence of Ureaplasma urealyticum isolated infection was 32.4%. A strong association was found between the presence of genital warts and Ureaplasma urealyticum infection, with an estimated risk of 1.230 (p=0.014). Conclusion: Our findings suggest the need for further investigation for Ureaplasma urealyticum infection in patients presenting genital warts on physical examination. In addition, in this context, greater attention should be given to women and pregnant women.

1 October 2015 in Revista Brasileira de Ginecologia e Obstetrícia
Verified
Journal Article
Open access
PDF file
KBKarina de Sá Adami Gonçalves Brandão
Karina de Sá Adami Gonçalves Brandão
BLBruno Gil de Carvalho Lima
Bruno Gil de Carvalho Lima
ATAna Gabriela Travassos
Ana Gabriela Travassos
FBFabielle de Oliveira Rocha de Brito
Fabielle de Oliveira Rocha de Brito
ESEveline Xavier Pereira de Souza
Eveline Xavier Pereira de Souza
CSCarlos Alberto Lima da Silva
Carlos Alberto Lima da Silva
To determine adherence to dual contraception using depot-medroxyprogesterone acetate (DMPA) and condom among HIV-infected women. A cross-sectional study carried out from December 2013 to September 2014 at a local reference center, with application of questionnaire elaborated after Delphi panel and content validation to 114 HIV(+) women aged 15 to 49 years, using DMPA plus condom for contraception. Mean age was 33.2 ± 7.2 years, mean time since HIV detection was 8.1 ± 5.2 years, mean time of antiretroviral use was 6.8 ± 5 years and mean CD4 cells/mm3 count was 737.6 ± 341.1. Sexual HIV acquisition was reported by 98.2% (112/114), antiretroviral use by 85.9% (98/114), and 77.7% (84/114) had a CD4>500/mm3 count. Having a single sex partner was reported by 78.9% (90/114), with HIV serodiscordance in 41.2% (47/114) of couples, 21.9% did not know the serological status of their partner and in 37.7% of cases (43/114) the partner was unaware of the HIV(+) status of the woman. The last pregnancy was unplanned in 71.9% of cases (82/114) and 14.9% of the women had become pregnant the year before, with pregnancy being unplanned in 70.5% (12/17) of cases. Current use of DMPA was reported by 64.9% (74/114), with genital bleeding in 48.2% (55/114) and weight gain in 67.5% (77/114). Use of a male condom was reported by 62.2% of the subjects (71/114). Three reported that they always used a female condom and ten that they eventually used it. Unprotected vaginal sex was reported by 37.7% (43/114) and unprotected anal intercourse was reported by 32.4% (37/114). Partner resistance to use a condom occurred in 30.7% of cases (35/114). Dual contraception using DMPA with condom was reported by 42.9% (49/114). A partner who resisted wearing a condom was associated with poor adhesion (PR=0.3; 95%CI 0.2-0.7; p<0.001). A partner who was unaware that a woman was infected with HIV favored adherence (PR=1.8; 95%CI 1.2-2.7; p=0.013). The percentage of dual contraception using DMPA plus condom was 42.9%, maintaining unplanned pregnancies and unprotected sex. Resistance of partners to use a condom increased three times the chance of a woman not adhering to dual contraception, and the partner not knowing women's HIV infection almost doubled the chance to adhere to safe contraception. to offer new hormonal contraceptives and to involve the partners in contraception and serologic detection tests.

8 July 2017
Verified
Conference Paper
Closed access
PDF file
RTRaiza Trindade
Raiza Trindade
EXEveline Xavier-Souza
Eveline Xavier-Souza
MTMaiara Timbó
Maiara Timbó
KLKrysna Lessa
Krysna Lessa
CSCamila Souza
Camila Souza
ATAna Gabriela Travassos
Ana Gabriela Travassos
Introduction The adolescence is a period marked by intense vulnerability, with a high prevalence of HPV, mostly of transient infections. We aimed to identify the population of adolescents infected with HPV and risk factors associated. Methods A cross-sectional study evaluating adolescents (from 10 to 19 years of age) carried out from January to August 2012 at the major Sexually Transmitted Infections (STI) Reference Centre in Bahia, Brazil. Sociodemographic and clinical data were obtained by reviewing charts and analysed through SPSS 20.0. Results Of the adolescents evaluated, 324 had the diagnosis of HPV, evidencing an HPV prevalence of 62.5%. Among those, the mean age was 16.8 (±1.5) years and the sexual debut occurred at 13.2 (±3.5) years of age. There was an association between the female gender and the diagnosis of HPV (p<0.01; OR 3.22, 95% CI 2.18–4.77), as well as to being 16 years old or older (p<0.01; OR 3.44, 95% CI 2.28–5.19). Regarding lifestyle, 25.6% (42/164) of HPV patients reported alcohol use, 8.1% (16/197) illicit drugs use and 2.2% (3/138) were smokers. There was a statistical correlation between having ≥8 years of schooling and HPV (p=0.02; OR 1.76, 95% CI 1.10–2.79), as well as working and the infection (p=0.01; OR 2.54, 95% CI 1.17–5.53). As for clinical characteristics, 15.8% (40/253) of HPV patients were pregnant during the study, with a significant association between pregnancy and the virus (p=0.02; OR 2.69, 95% CI 1.10–6.58). There was 91.9% (295/321) of clinical diagnosis of HPV, and 61.9% (199/321) of genital warts among the infected population. 90.9% (280/308) of the infected adolescents underwent treatment for HPV. Conclusion The clinical and epidemiological profile of these adolescents revealed the need for prevention campaigns against STIs with accessible language, promoting access to information. Access to HPV vaccine is now possible, and it is still necessary to stimulate follow-up and treatment in order to reduce this infection and its associated diseases.

8 July 2017
Verified
Conference Paper
Closed access
PDF file
KPKrysna Pires
Krysna Pires
EXEveline Xavier-Souza
Eveline Xavier-Souza
MTMaiara Timbó
Maiara Timbó
RTRaiza Trindade
Raiza Trindade
CSCamila Souza
Camila Souza
ATAna Gabriela Travassos
Ana Gabriela Travassos
Introduction Recently, the number of adolescents infected with HIV has been increasing worldwide, but there is still little information available on the characteristics of this population. The aim of this study is to compare the characteristics of adolescents living with HIV attending a Sexually Transmitted Infection (STI) Referral Centre according to the modes of transmission. Methods A cross-sectional study evaluating adolescents between 10 and 19 years of age, carried out from January to August 2012, at the state STI reference centre in Bahia, Brazil. Sociodemographic and clinical data were obtained by reviewing charts and analysed through SPSS 20.0. Results A total of 123 adolescents living with HIV were attended during the study period, 76.3% (90/118) of them acquired the virus through vertical transmission (VT), whereas 22.9% (27/118) acquired via sexual transmission (ST). Regarding the adolescents with VT, the group was younger than the ST, with 93.7%<16 years old (p<0.01, OR 20.35, 95% CI 6.70–61.83); 78.9% attended school (p<0.01, OR 0.15, 95% CI 0.04–0.61), 62.1% did not work (p=0.02), 55.2% denied use of alcohol (p<0.01, OR 0.07, 95% CI 0.01–0.65), and 98.7% also denied sexual debut (p<0.01, OR <0.01, 95% CI 0.00–0.03). On the other hand, patients with a ST infection started their sexual life earlier, with a mean age of 12.9 (±3.74) years, 93.8% of them had had previous gestation (p<0.01, OR 27.5, 95% CI 2.89–262.3), 75.0% had HPV co-infection (p<0.01, OR 11.5, 95% CI 2.03–64.78) and 88.9% had another STI in the period (p<0.01, OR 45.71, 95% CI 5.30–394.42). The VT group showed rates of 93,5% of AIDS diagnosis (p<0.01, OR 72., 95% CI 16.41–315.98) and 100% (p=0.01) had had opportunistic infections; 93,1% performed genotyping (p=0.02, OR 5.87, 95% CI 1.27–27.09) and 85.4% used ART (p<0.01, OR 8.54, 95% CI 2.72–26.85). Conclusion We observed two distinct groups, defined according to the modes of transmission, both showing specific characteristics. Thus, is it evident the need of customise the health care and promotion according to each group.